Latest Conference

Explore how circadian gene rhythms differ in schizophrenia, depression, and bipolar disorder—and why stable sleep timing may curb addiction risk.

Sleep and circadian rhythm disruption shape psychiatric symptoms and bipolar mood shifts.

Alkermes’ phase 2 Vibrance-2 shows alixorexton significantly boosts wakefulness and reduces daytime sleepiness in narcolepsy type 2, with benefits sustained.

New SLEEP 2026 data show orexin agonist oveporexton boosts cognition, daily function, and reduces microsleeps in narcolepsy type 1.

Check out new phase 2 dose-ranging study data evaluating alixorexton in patients with narcolepsy type 2.

REFRESH data show once-nightly sodium oxybate real-world outcomes.

REFRESH real-world study follows once-nightly sodium oxybate in narcolepsy.

Midlife sleep trouble predicts poorer well-being 9 years later, especially for women. Here's why clinicians should ask about sleep and menopause triggers.

Long-term study links sleep problems to poorer well-being in aging adults, highlighting sex differences and why insomnia isn’t just aging.

New spectral sleep analysis and HD‑tDCS aim to strengthen restorative sleep and memory, offering promise for schizophrenia-related cognitive deficits.

New SLEEP 2026 insights reveal how REM sleep preserves memories while stripping emotional sting—key clues for PTSD and healthier sleep.

Behavioral therapies: important parts of sleep disorder treatment.

Menopause-related sleep disruptions and slow-wave scoring bias may skew women’s neurodegeneration risk insights, SLEEP 2026 highlights.

Explore how digital reminders boost prospective memory in aging and dementia, plus practical sleep habits that turn health knowledge into real behavior changes.

Learn more about the bidirectional relationship between sleep and waking behaviors.

Learn why awakenings are normal, sleep needs shift with age, and deep sleep protects brain health and cognition.

New research links sleep inertia and daytime sleepiness to dangerous falls in older adults—learn which sleep habits may prevent injuries.

Learn more about sleep issues and their relation to Alzheimer disease.

New research links better NREM sleep to slower Alzheimer disease changes: zolpidem restores brain rhythms, cuts amyloid, and boosts memory in mice models.

Explore the intersections of bipolar disorder with clinical trials and AI.

Teens’ pre-bed smartphone scrolling drives more late-night phone use, disrupting sleep and potentially worsening mental health—experts urge bedtime screen limits and device-free bedrooms.

Carlos H. Schenck, MD, delivered the keynote address at SLEEP 2026 on REM sleep behavior disorder. Here's what psychiatrists and mental health clinicians need to know.

Let's take a look at the next generation of pharmacotherapies for mood and anxiety disorders.

In this inaugural episode, experts discuss the limitations of current diagnosis-based frameworks in suicide research, emphasizing the need for more targeted interventions.

In the first ever episode of "Psychopharm Today," experts unpack why suicide needs its own research, how to design targeted studies, and what clinicians can do beyond diagnosis to reduce risk.

Discover an objective suicide risk assessment for patients denying ideation, using Suicide Crisis Syndrome and staged warning signs to guide earlier intervention.

Blood exosomal microRNA markers reveal oxidative-stress subtypes, predict psychosis conversion, and guide early, targeted treatments like MitoQ.

Yale psychiatrists test esketamine vs IV ketamine for resistant depression, probing long-term safety, side effects, and misuse in real-world care.